reported that GBM cells with functionally intact p53 genes were more sensitive to TMZ treatment due to the activation of the Fas/CD95/APO-1 receptor and the subsequent apoptosis triggered by O6-methylguanine, a product of TMZ-induced DNA damage (66). The gene discussed is TP53; the disease is glioblastoma.